Skip to main content
Caplight Logo









Qentoros, Inc.

Qentoros, Inc.

Private
Blacksburg, VirginiaHealthcare & Life Scienceshttps://www.qentoros.com/

Last Round

Seed Round

Aug 28, 2026

Total Funding Raised

$120,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Qentoros, Inc. is a biotechnology company that develops orthobiologic therapeutics derived from platelets for the treatment of musculoskeletal injuries in animals and humans.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

orthobiologicsveterinary medicineregenerative medicineequine veterinaryplatelet-rich plasmaPRPbiotech startupmusculoskeletal injuryallogenic therapyFDA-CVMveterinary biologicsvet techclinical trialsorthopedic treatmentbioprocessing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qentoros, Inc. Comparables

Compare Qentoros, Inc. with similar companies based on industry and business-model similarity.

Qentoros, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EQGen Biomedical
89%
AniCell Biotech
86%
Pegasus Orthobiologics Corporation
84%

Qentoros, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundAug 28, 2026
SeedDec 17, 2025
AcceleratorSep 21, 2022

Key People

Founding team and executive leadership

Lauren V. Schnabel

Co-founder, CMO

Founding Team

Jessica Gilbertie

Founder and Chief Executive Officer

Founding Team

Qentoros, Inc. Investors

Notable investors and investment history

Qentoros, Inc. investors
InvestorRounds
Regional Accelerator and Mentoring ProgramAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 28, 2026

    $505K raised in Seed Round.

  • Dec 17, 2025

    $100K round completed.

Qentoros, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qentoros, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qentoros, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBlacksburg, Virginia
Employee Range6
Year Founded2022
Last FundingAug 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?